Highbridge Capital Management LLC has filed its 13F form on February 12, 2025 for Q4 2024 where it was disclosed a total value porftolio of $435 Million distributed in 304 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Hess Corp with a value of $77.1M, Allete Inc with a value of $54.6M, Summit Materials, Inc. with a value of $38.1M, Frontier Communications Parent, Inc. with a value of $37.6M, and Amedisys Inc with a value of $34.6M.
Examining the 13F form we can see an increase of $102M in the current position value, from $333M to 435M .
Highbridge Capital Management LLC is based out at New York, NY
Below you can find more details about Highbridge Capital Management LLC portfolio as well as his latest detailed transactions.
Portfolio value
$435 Million
$79.8 Million
$77.1 Million
$54.6 Million
$54 Million
$50.3 Million
$38.1 Million
$36.7 Million
$34.6 Million
$5.9 Million
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 16.54%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
Added 47.84%
-
$0
0.0% of portfolio
-
Q4 2024
New
Nabors Energy Transition Cor
-
$0
0.0% of portfolio
-
Q4 2023
Added 1,261.19%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 29.98%
-
$0
0.0% of portfolio
-
Q4 2024
New
Melar Acquisition Corp. I
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 40.0%
Melar Acquisition Corp. I
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q1 2023
Reduced 3.04%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 3.86%
-
$0
0.0% of portfolio
-
Q4 2024
New
M3 Brigade Acquisition V Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 0.33%
-
$0
0.0% of portfolio
-
Q1 2024
New
Jackson Acquisition CO Ii
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2024
New
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q3 2024
Added 6.1%
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 7.75%
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 37.25%
Integra Lifesciences Hldgs C
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 71.24%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 18.06%
Inovio Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 7.14%
Inflection Pt Acquisitn Crp
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 17.33%
-
$0
0.0% of portfolio
-
Q2 2024
New
Hudson Acquisition I Corp
-
$0
0.0% of portfolio
-
Q1 2023
Reduced 94.43%
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Added 15.91%
-
$0
0.0% of portfolio
-
Q4 2024
Added 59.67%
-
$0
0.0% of portfolio
-
Q4 2024
Added 12.59%
-
$0
0.0% of portfolio
-
Q4 2024
Added 81.48%
-
$0
0.0% of portfolio
-
Q4 2024
Added 228.05%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 62.44%
-
$0
0.0% of portfolio
-
Q2 2024
Added 1,053.85%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 62.46%
Keen Vision Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2024
Reduced 25.92%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 30.0%
Launch One Acquisition Corp
-
$0
0.0% of portfolio
-
Q4 2024
Added 56.62%
Launch One Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
Lanvin Group Holdings Limite
-
$0
0.0% of portfolio
-
Q4 2023
Added 2.18%
Horizon Space Acqustn I Corp
-
$0
0.0% of portfolio
-
Q1 2023
Reduced 31.25%
Oaktree Acquisition Corp Iii
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 80.0%
Trailblazer Merger Corp I
-
$0
0.0% of portfolio
-
Q4 2024
Added 120.52%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 39.76%
-
$0
0.0% of portfolio
-
Q4 2024
Added 24.23%
-
$0
0.0% of portfolio
-
Q4 2024
New
